IL225010A - Methyl (2s, 3r) –1 - ((1s) –2 - (- 2 - (- 5 - ((2r, 3r) –1–) (3,5, diplooro – 4– (4– (4 – fluorophenyl) Piperidine-1-ram (phenyl) -5- (6-fluoro-2 - ((2 s) –1- (n- (methoxycarbonyl) - o- methyl- l-thronyl) pyrrolidine-1-ram) -1-benzoimidazole -5-ram (pyrrolidine-2-ram) -6-fluoro-1-h-benzimidazole-2-ram (pyrrolidine-1-ram) -3-methoxy-1-oxobutane-2-ram) carbamate and the pharmacy composition containing it - Google Patents

Methyl (2s, 3r) –1 - ((1s) –2 - (- 2 - (- 5 - ((2r, 3r) –1–) (3,5, diplooro – 4– (4– (4 – fluorophenyl) Piperidine-1-ram (phenyl) -5- (6-fluoro-2 - ((2 s) –1- (n- (methoxycarbonyl) - o- methyl- l-thronyl) pyrrolidine-1-ram) -1-benzoimidazole -5-ram (pyrrolidine-2-ram) -6-fluoro-1-h-benzimidazole-2-ram (pyrrolidine-1-ram) -3-methoxy-1-oxobutane-2-ram) carbamate and the pharmacy composition containing it

Info

Publication number
IL225010A
IL225010A IL225010A IL22501013A IL225010A IL 225010 A IL225010 A IL 225010A IL 225010 A IL225010 A IL 225010A IL 22501013 A IL22501013 A IL 22501013A IL 225010 A IL225010 A IL 225010A
Authority
IL
Israel
Prior art keywords
pyrrolidin
benzimidazol
fluoro
methyl
oxobutan
Prior art date
Application number
IL225010A
Other languages
English (en)
Hebrew (he)
Original Assignee
Abbvie Bahamas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/903,822 external-priority patent/US20110092415A1/en
Priority claimed from US13/100,827 external-priority patent/US8937150B2/en
Application filed by Abbvie Bahamas Ltd filed Critical Abbvie Bahamas Ltd
Publication of IL225010A publication Critical patent/IL225010A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
IL225010A 2010-10-13 2013-02-28 Methyl (2s, 3r) –1 - ((1s) –2 - (- 2 - (- 5 - ((2r, 3r) –1–) (3,5, diplooro – 4– (4– (4 – fluorophenyl) Piperidine-1-ram (phenyl) -5- (6-fluoro-2 - ((2 s) –1- (n- (methoxycarbonyl) - o- methyl- l-thronyl) pyrrolidine-1-ram) -1-benzoimidazole -5-ram (pyrrolidine-2-ram) -6-fluoro-1-h-benzimidazole-2-ram (pyrrolidine-1-ram) -3-methoxy-1-oxobutane-2-ram) carbamate and the pharmacy composition containing it IL225010A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/903,822 US20110092415A1 (en) 2009-06-11 2010-10-13 Anti-Viral Compounds
US12/964,027 US8921514B2 (en) 2009-06-11 2010-12-09 Anti-viral compounds
US201161446800P 2011-02-25 2011-02-25
US13/100,827 US8937150B2 (en) 2009-06-11 2011-05-04 Anti-viral compounds
PCT/US2011/056045 WO2012051361A1 (en) 2010-10-13 2011-10-12 Anti-viral compounds

Publications (1)

Publication Number Publication Date
IL225010A true IL225010A (en) 2016-04-21

Family

ID=55069204

Family Applications (2)

Application Number Title Priority Date Filing Date
IL225010A IL225010A (en) 2010-10-13 2013-02-28 Methyl (2s, 3r) –1 - ((1s) –2 - (- 2 - (- 5 - ((2r, 3r) –1–) (3,5, diplooro – 4– (4– (4 – fluorophenyl) Piperidine-1-ram (phenyl) -5- (6-fluoro-2 - ((2 s) –1- (n- (methoxycarbonyl) - o- methyl- l-thronyl) pyrrolidine-1-ram) -1-benzoimidazole -5-ram (pyrrolidine-2-ram) -6-fluoro-1-h-benzimidazole-2-ram (pyrrolidine-1-ram) -3-methoxy-1-oxobutane-2-ram) carbamate and the pharmacy composition containing it
IL261206A IL261206B (en) 2010-10-13 2018-08-16 Anti-viral compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL261206A IL261206B (en) 2010-10-13 2018-08-16 Anti-viral compounds

Country Status (19)

Country Link
JP (4) JP2016106075A (sl)
KR (1) KR101990936B1 (sl)
CA (1) CA2938547A1 (sl)
CY (1) CY1117188T1 (sl)
DK (1) DK2692346T3 (sl)
ES (1) ES2560842T3 (sl)
GT (1) GT201300093AA (sl)
HK (1) HK1188717A1 (sl)
HR (1) HRP20151389T1 (sl)
HU (1) HUE026832T2 (sl)
IL (2) IL225010A (sl)
ME (1) ME02328B (sl)
MY (1) MY164064A (sl)
PT (1) PT2692346E (sl)
RS (1) RS54619B1 (sl)
SI (1) SI2692346T1 (sl)
TW (1) TWI621611B (sl)
UA (1) UA113048C2 (sl)
ZA (3) ZA201302269B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201706806D0 (en) 2017-04-28 2017-06-14 Sentinel Oncology Ltd Pharmaceutical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9206623A (pt) * 1991-10-11 1995-05-02 Du Pont Merck Pharma Uréias cíclicas e análogas úteis como inibidoras da protease retroviral
US5840721A (en) * 1997-07-09 1998-11-24 Ontogen Corporation Imidazole derivatives as MDR modulators
US8329159B2 (en) * 2006-08-11 2012-12-11 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7741347B2 (en) * 2007-05-17 2010-06-22 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
NZ593806A (en) * 2008-12-03 2014-04-30 Presidio Pharmaceuticals Inc Inhibitors of hcv ns5a
US9394279B2 (en) * 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
JP5530514B2 (ja) * 2009-06-11 2014-06-25 アッヴィ・バハマズ・リミテッド Ｈｃｖ感染を治療するための抗ウィルス化合物
US8937150B2 (en) * 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds

Also Published As

Publication number Publication date
PT2692346E (pt) 2016-03-22
JP2016106075A (ja) 2016-06-16
HRP20151389T1 (hr) 2016-01-15
SI2692346T1 (sl) 2016-03-31
JP6586147B2 (ja) 2019-10-02
DK2692346T3 (en) 2016-02-29
ME02328B (me) 2016-06-20
MY164064A (en) 2017-11-15
UA113048C2 (xx) 2016-12-12
HUE026832T2 (en) 2016-07-28
RS54619B1 (en) 2016-08-31
IL261206B (en) 2019-12-31
TW201412707A (zh) 2014-04-01
HK1188717A1 (zh) 2014-05-16
ZA201705519B (en) 2019-04-24
JP2020059696A (ja) 2020-04-16
JP2018065828A (ja) 2018-04-26
CY1117188T1 (el) 2017-04-05
KR101990936B1 (ko) 2019-06-19
KR20180026775A (ko) 2018-03-13
ZA201302269B (en) 2021-05-26
JP6790202B2 (ja) 2020-11-25
CA2938547A1 (en) 2012-04-19
JP2021035964A (ja) 2021-03-04
IL261206A (en) 2018-10-31
ES2560842T3 (es) 2016-02-23
GT201300093AA (es) 2015-07-08
ZA201903284B (en) 2021-01-27
TWI621611B (zh) 2018-04-21

Similar Documents

Publication Publication Date Title
EA033332B1 (ru) Способ получения метил {(2s,3r)-1-[(2s)-2-{5-[(2r,5r)-1-{3,5-дифтор-4-[4-(4-фторфенил)пиперидин-1-ил]фенил}-5-(6-фтор-2-{(2s)-1-[n-(метоксикарбонил)-о-метил-l-треонил]пирролидин-2-ил}-1н-бензимидазол-5-ил)пирролидин-2-ил]-6-фтор-1н-бензимидазол-2-ил}пирролидин-1-ил]-3-метокси-1-оксобутан-2-ил} карбамата
IL215094A (en) Methyl [1– {2– [5– (10– {2– [1– {2– [Methoxycarbonyl) Amino] –3 – Methylbutanoyl} pyrrolidin-2-yl] - h1– Amidazole-5-Ill} –6– Phenylindolo [2,1- c] [3,1] benzoxazine-3-yl) - h 1-amidazole-2-yl] pyrrolidin-1-yl} -3-methyl-1-oxobutan-2-yl] carbamate and preparations Hcv delay pharmacy containing it
AR104566A2 (es) Forma cristalina de la sal diclorhidrato de ((1s)-1-(((2s)-2-(5-(4-(2-((2s)-1-((2s)-2-((metoxicarbonil)amino)-3-metilbutanoil)-2-pirrolidinil)-1h-imidazol-5-il)-4-bifenilil)-1h-imidazol-2-il)-1-pirrolidinil)carbonil)-2-metilpropil)carbamato de metilo
NZ630581A (en) Methods for treating hepatitis c
PE20160800A1 (es) Combinacion de metil ((1s)-1-(((2s)-2-(5-(4’-(2-((2s)-2-((metoxicarbonil)amino)-3-metilbutanoil)-2-pirrolidinil)-1h-imidazol-5-il)-4-bifenilil)-1h-imidazol-2-il-1-pirrolidinil)carbonil)-2-metilpropil)carbamato (daclatasvir) y n-(tert-butoxicarbonil)-3-metil-l-valil-(4r)-4-((7-cloro-4-metoxi-1-isoquinolinil)oxi-n-((1r,2s)-1-((ciclopropilsulfonil)carbamoil)-2-vinilciclopropil)-l-prolinamida (asunaprevir).
RS54282B1 (en) SOLID MIXTURES
NO20084924L (no) N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
AT509493A5 (de) Feste arzneiform von olmesartan medoxomil und amlodipin
EP2244576A4 (en) 1,3-OXAZOLIDIN-2-ONE 3,5-SUBSTITUTED DERIVATIVES
GB0623012D0 (en) Diphyllin and other lignans as a medicament for V-ATPase mediated disease
BRPI0905388A2 (pt) "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"
EP2015800A4 (en) MEDICAL INJECTOR WITH FRONT LOADING AND CORRESPONDING SYRINGES
PE20140409A1 (es) Derivados de 4-(5-ciano-pirazol-1-il)-piperidina como moduladores de gpr 119
TW200800954A (en) Novel crystal modifications
ZA201101894B (en) Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
BR112013010704A2 (pt) uma composição compreendendo s-[2-([[1-(2-etilbutila)-ciclohexila]-carbonila]amino)fenila]2-metilpropanotioato e croscarmelose de sódio
IL225010A (en) Methyl (2s, 3r) –1 - ((1s) –2 - (- 2 - (- 5 - ((2r, 3r) –1–) (3,5, diplooro – 4– (4– (4 – fluorophenyl) Piperidine-1-ram (phenyl) -5- (6-fluoro-2 - ((2 s) –1- (n- (methoxycarbonyl) - o- methyl- l-thronyl) pyrrolidine-1-ram) -1-benzoimidazole -5-ram (pyrrolidine-2-ram) -6-fluoro-1-h-benzimidazole-2-ram (pyrrolidine-1-ram) -3-methoxy-1-oxobutane-2-ram) carbamate and the pharmacy composition containing it
IL210141A0 (en) Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide
EA201001125A1 (ru) Фармацевтические композиции, включающие n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамид
EP2305644A4 (en) ARALKYL ALCOHOL PIPERIDINE DERIVATIVES AND THEIR USE AS A MEDICAMENT FOR THE TREATMENT OF DEPRESSION
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
NZ715562A (en) Anti-viral compounds
ES1064442Y (es) Maquina recolectora de almendras y similares
MX2014006448A (es) Composicion farmaceutica para evitar o tratar hiperlipidemia.
TW200833325A (en) Pharmaceutical composition comprising ascorbic acid

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years